Literature DB >> 21367621

Cannabis-related stroke: case series and review of literature.

Niranjan N Singh1, Yi Pan, Sombat Muengtaweeponsa, Thomas J Geller, Salvador Cruz-Flores.   

Abstract

Marijuana, or cannabis, is one of the most commonly used illicit drugs worldwide. Although there are some case reports of stroke associated with cannabis use, there is no information on a causal role of cannabis in stroke. We identified 14 patients admitted to St Louis University Hospital between January 2004 and July 2007 with ischemic stroke who had documented clear exposure to cannabis during or before symptom onset and a positive urine screen for cannabis. We report this series, along with 3 cases previously reported by our group, for a total of 17 patients (13 men and 4 women), with a mean age of 41 years (range, 15-63 years). Nine patients were under age 45 years, 4 had a history of hypertension, and 10 sustained stroke in the posterior circulation. Headache, dysarthria, and ataxia were the most common presenting symptoms. Five patients had recurrent stroke with reexposure to cannabis. No patient had a prothrombotic state or cardiac source of embolism. Autopsy performed in 2 patients revealed hemorrhagic infarct with no evidence of vasculitis or embolus. The absence of other vascular risk factors in most of our patients, the temporal relation of symptom onset to cannabis exposure, and the recurrence of symptoms in a few patients with reexposure suggest a causal role of cannabis in these cases of ischemic stroke. However, this causal association cannot be definitely ascertained, given the descriptive nature of our series. More research is needed to explore this possible causal association.
Copyright © 2012 National Stroke Association. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21367621     DOI: 10.1016/j.jstrokecerebrovasdis.2010.12.010

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  26 in total

Review 1.  Triphasic blood pressure responses to cannabinoids: do we understand the mechanism?

Authors:  Barbara Malinowska; Marta Baranowska-Kuczko; Eberhard Schlicker
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

2.  A case of ischemic stroke after bonzai: syntetic cannabinoid from Turkey.

Authors:  Yildiz Degirmenci; Hulusi Kececi; Nurten Olmez
Journal:  Neurol Sci       Date:  2015-10-14       Impact factor: 3.307

Review 3.  Risks associated with the non-medicinal use of cannabis.

Authors:  Eva Hoch; Udo Bonnet; Rainer Thomasius; Florian Ganzer; Ursula Havemann-Reinecke; Ulrich W Preuss
Journal:  Dtsch Arztebl Int       Date:  2015-04-17       Impact factor: 5.594

4.  Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity.

Authors:  Nora D Volkow; Gene-Jack Wang; Frank Telang; Joanna S Fowler; David Alexoff; Jean Logan; Millard Jayne; Christopher Wong; Dardo Tomasi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-14       Impact factor: 11.205

Review 5.  Drug abuse and stroke.

Authors:  Ana Catarina Fonseca; José M Ferro
Journal:  Curr Neurol Neurosci Rep       Date:  2013-02       Impact factor: 5.081

6.  An unusual postoperative cerebral ischemic stroke.

Authors:  Rudin Domi; Aurel Janko; Hektor Sula
Journal:  J Anesth       Date:  2014-06-28       Impact factor: 2.078

7.  Stroke due to Bonzai use: two patients.

Authors:  Baki Dogan; Hakan Dogru; Levent Gungor; Kemal Balci
Journal:  World J Emerg Med       Date:  2016

8.  Delayed Intracerebral Hemorrhage after Synthetic Cannabis (Bonsai) Abuse; Case Report and Literature Review.

Authors:  Gülçin Aydin; Bülent Bakar
Journal:  Bull Emerg Trauma       Date:  2019-07

9.  Decreased consciousness: bilateral thalamic infarction and its relation to the artery of Percheron.

Authors:  Jennifer Turner; Tejal Richardson; Ingrid Kane; Sriram Vundavalli
Journal:  BMJ Case Rep       Date:  2014-01-16

Review 10.  What is the Current Knowledge About the Cardiovascular Risk for Users of Cannabis-Based Products? A Systematic Review.

Authors:  Emilie Jouanjus; Valentin Raymond; Maryse Lapeyre-Mestre; Valérie Wolff
Journal:  Curr Atheroscler Rep       Date:  2017-06       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.